Skip to main content

Psychotherapy

0
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Linnaeus Therapeutics
Linnaeus TherapeuticsNJ - Haddonfield
1 program
Intensive Short-Term Dynamic PsychotherapyN/A1 trial
Active Trials
NCT05863637Unknown30Est. Dec 2025
Eppendorf
EppendorfGermany - Hamburg
1 program
MAC-cbt group treatment for adult ADHDN/A1 trial
Active Trials
NCT03806569Unknown180Est. Dec 2022

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Linnaeus TherapeuticsIntensive Short-Term Dynamic Psychotherapy
EppendorfMAC-cbt group treatment for adult ADHD

Clinical Trials (2)

Total enrollment: 210 patients across 2 trials

NCT05863637Linnaeus TherapeuticsIntensive Short-Term Dynamic Psychotherapy

Intensive Short-Term Dynamic Psychotherapy (ISTDP) for Anxiety Diagnoses in a Primary Care Setting

Start: Sep 2023Est. completion: Dec 202530 patients
N/AUnknown
NCT03806569EppendorfMAC-cbt group treatment for adult ADHD

MAC-cbt Group Therapy for Adults With ADHD

Start: Mar 2019Est. completion: Dec 2022180 patients
N/AUnknown

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.